COVID-19: Possible Cause of Induction of Relapse of Plasmodium vivax Infection.
作者信息
Kishore Rashmi, Dhakad Shivram, Arif Nazneen, Dar Lalit, Mirdha B R, Aggarwal Richa, Kabra S K
机构信息
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Indian J Pediatr. 2020 Sep;87(9):751-752. doi: 10.1007/s12098-020-03441-6. Epub 2020 Jul 3.
Abstract
摘要
相似文献
1
COVID-19: Possible Cause of Induction of Relapse of Plasmodium vivax Infection.新型冠状病毒肺炎：间日疟原虫感染复发诱导的可能原因
Indian J Pediatr. 2020 Sep;87(9):751-752. doi: 10.1007/s12098-020-03441-6. Epub 2020 Jul 3.
2
Coinfections with SARS-CoV-2 and other respiratory pathogens.新型冠状病毒（SARS-CoV-2）与其他呼吸道病原体的合并感染。
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1228-1229. doi: 10.1017/ice.2020.322. Epub 2020 Jul 3.
3
Could the COVID-19 pandemic aggravate antimicrobial resistance?新冠疫情会加剧抗菌药物耐药性吗？
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
4
Four Patients with COVID-19 and Tuberculosis, Singapore, April-May 2020.2020 年 4 月至 5 月，新加坡 4 例 COVID-19 合并结核病患者。
Emerg Infect Dis. 2020 Nov;26(11):2764-2766. doi: 10.3201/eid2611.202752. Epub 2020 Jul 15.
5
Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January-February 2020.中国武汉，2020 年 1 月至 2 月，3 例新冠肺炎合并肺结核患者。
Emerg Infect Dis. 2020 Nov;26(11):2755-2758. doi: 10.3201/eid2611.201536. Epub 2020 Jul 15.
6
Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options.新冠肺炎阳性患者的真菌感染：缺乏最佳治疗方案
Curr Top Med Chem. 2020;20(22):1951-1957. doi: 10.2174/156802662022200917110102.
7
Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19.既往和活动性肺结核会增加 COVID-19 患者的死亡风险并延长其康复时间。
Infect Dis (Lond). 2020 Nov-Dec;52(12):902-907. doi: 10.1080/23744235.2020.1806353. Epub 2020 Aug 18.
8
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic.新冠疫情期间多重耐药耳念珠菌这一潜在祸害。
J Glob Antimicrob Resist. 2020 Sep;22:175-176. doi: 10.1016/j.jgar.2020.06.003. Epub 2020 Jun 12.
9
Hematuria Associated With SARS-CoV-2 Infection in a Child.一名儿童感染新型冠状病毒后出现血尿
Pediatr Infect Dis J. 2020 Jul;39(7):e161. doi: 10.1097/INF.0000000000002737.
10
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
引用本文的文献
1
Coinfection of COVID-19 and malaria: clinical profiles, interactions, and strategies for effective control.新型冠状病毒肺炎与疟疾的合并感染：临床特征、相互作用及有效控制策略
Malar J. 2025 Mar 25;24(1):99. doi: 10.1186/s12936-025-05315-8.
2
COVID-19 and malaria co-infection: a systematic review of clinical outcomes in endemic areas.新型冠状病毒肺炎与疟疾合并感染：流行地区临床结局的系统评价
PeerJ. 2024 Apr 18;12:e17160. doi: 10.7717/peerj.17160. eCollection 2024.
3
SARS-CoV-2 decreases malaria severity in co-infected rodent models.SARS-CoV-2 降低了感染鼠模型中的疟疾严重程度。
Front Cell Infect Microbiol. 2023 Dec 13;13:1307553. doi: 10.3389/fcimb.2023.1307553. eCollection 2023.
4
A Surge in Malaria Cases in the Eastern Health Region of Saudi Arabia During the COVID-19 Pandemic.新冠疫情期间沙特阿拉伯东部卫生区域疟疾病例激增。
Cureus. 2023 Apr 17;15(4):e37740. doi: 10.7759/cureus.37740. eCollection 2023 Apr.
5
Co-infection of COVID-19 and parasitic diseases: A systematic review.新型冠状病毒肺炎与寄生虫病的合并感染：一项系统综述。
Parasite Epidemiol Control. 2023 May;21:e00299. doi: 10.1016/j.parepi.2023.e00299. Epub 2023 Mar 30.
6
Third Case of Visceral Leishmaniasis in COVID-19: Mini Review Article.新型冠状病毒肺炎合并内脏利什曼病的第三例病例：综述文章
Pathogens. 2022 Aug 14;11(8):913. doi: 10.3390/pathogens11080913.
7
MIS-C and co-infection with P. vivax and P. falciparum in a child: a clinical conundrum.儿童川崎病合并间日疟原虫和恶性疟原虫混合感染：一个临床难题。
Ital J Pediatr. 2022 Jul 27;48(1):130. doi: 10.1186/s13052-022-01311-9.
8
Co-Infection with and COVID-19 in Thailand.泰国的[病原体名称]与新冠病毒共同感染情况。 （你原文中“Co-Infection with and COVID-19”这里“with”后面缺少具体病原体名称，我先按这种形式翻译了，你可补充完整后再让我准确翻译）
Trop Med Infect Dis. 2022 Jul 22;7(8):145. doi: 10.3390/tropicalmed7080145.
9
Prolonged fever and exaggerated hypercoagulopathy in malaria vivax relapse and COVID-19 co-infection: a case report.疟原虫 vivax 复发和 COVID-19 合并感染时出现长期发热和明显高凝状态：一例报告。
Malar J. 2022 Jun 23;21(1):199. doi: 10.1186/s12936-022-04215-5.
10
The First Reported Case of COVID-19 and Malaria Coinfection - Guangdong Province, China, January 2021.2021年1月中国广东省首例新型冠状病毒肺炎与疟疾合并感染报告病例
China CDC Wkly. 2021 May 21;3(21):454-455. doi: 10.46234/ccdcw2021.101.
本文引用的文献
1
COVID-19 in Children: Clinical Approach and Management.儿童 COVID-19：临床方法与管理。
Indian J Pediatr. 2020 Jun;87(6):433-442. doi: 10.1007/s12098-020-03292-1. Epub 2020 Apr 27.
2
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
3
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
4
Determinants of relapse periodicity in Plasmodium vivax malaria.影响间日疟复发周期性的因素。
Malar J. 2011 Oct 11;10:297. doi: 10.1186/1475-2875-10-297.
Zotero 插件